Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-18

FDA Approved: TOPIRAMATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves a supplemental application for TOPIRAMATE from Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE)